Bio/Pharmaceutical Analysis Techniques

Under the partnership, Sartorius will leverage SPARTA Biodiscovery’s technology to accelerate development of nanoparticles used for drug delivery.

Waters XBridge Premier GTx BEH size exclusion chromatography (SEC) columns are designed to improve analysis while lowering the cost of gene therapies.

Sartorius and Waters will collaborate to develop integrated analytical solutions for downstream biomanufacturing.

The Agilent 8697 Headspace Sampler-XL Tray has a 120-vial capacity.

Mass spectrometric techniques are providing insights in critical RNA-based therapeutic areas.

The collaboration will see Shimadzu and UMG develop new clinical laboratory methods using LC-MS for TDM analysis.

Analyzing elemental impurities in drug products is—much like other analytical testing—primarily aimed at ensuring patient safety.

Fresh insight is instrumental in the discussion of novel analytics.

The Thermo Scientific Ramina Process Analyzer is designed with user ease at the forefront.

Thermo Fisher and Symphogen have extended their collaboration involving improved data workflow, which supports the discovery and development of new cancer treatments.

The acquisition and analysis of MS data can be made more efficient with the integration of modern software tools.

A new portfolio of chromatography and mass spectrometry consumables launched by Thermo Fisher Scientific is designed to meet higher performance requirements while remaining economical.

The partnership between Waters and Sartorius aims to accelerate speed and increase accuracy in bioprocessing analysis.

Thermo Fisher Scientific showcases its new mass spectrometry and chromatography solutions at the ASMS Conference on Oct. 31–Nov. 4, 2021.

CuriRx’s CuriLytics platform is a mass spectrometry instrument that will support complex biotherapeutics development.

Intelligent analytical tools detect impurities to help ensure the quality of small-molecule drug ingredients.

New challenges arise in extractable and leachable studies for cell and gene therapy products.

Mass spectrometry and automation are growing in importance for protein characterization, but further improvements are still needed.

A well-chosen replication strategy can effectively reduce the uncertainty for an analytical method, enabling appropriate decisions regarding pharmaceutical quality.

Raman spectroscopy delivers real time, non-destructive process insights for critical process parameters to monitor pharmaceutical manufacturing.

The need for real-time monitoring and control has spurred the development of new analytical tools.

Common approaches to analyze elemental impurities for compliance with regulatory requirements are robust but still have some limitations.

Having a clear and detailed understanding of exactly what a biomolecule entails is essential for therapeutics development.

The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.